table of content
1 Introduction to Research & Analysis Reports
1.1 Drugs for Treating Mental Disorders Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Treating Mental Disorders Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Treating Mental Disorders Overall Market Size
2.1 Global Drugs for Treating Mental Disorders Market Size: 2022 VS 2030
2.2 Global Drugs for Treating Mental Disorders Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Treating Mental Disorders Players in Global Market
3.2 Top Global Drugs for Treating Mental Disorders Companies Ranked by Revenue
3.3 Global Drugs for Treating Mental Disorders Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Treating Mental Disorders Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drugs for Treating Mental Disorders Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Treating Mental Disorders Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Treating Mental Disorders Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Treating Mental Disorders Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Treating Mental Disorders Market Size Markets, 2022 & 2030
4.1.2 Tablets
4.1.3 Capsule
4.1.4 Injection
4.1.5 Solution
4.1.6 Other
4.2 By Type - Global Drugs for Treating Mental Disorders Revenue & Forecasts
4.2.1 By Type - Global Drugs for Treating Mental Disorders Revenue, 2018-2023
4.2.2 By Type - Global Drugs for Treating Mental Disorders Revenue, 2024-2030
4.2.3 By Type - Global Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Treating Mental Disorders Market Size, 2022 & 2030
5.1.2 Antipsychotics
5.1.3 Antidepressants
5.1.4 Antianxiety (Anxiolyitcs)
5.1.5 Anti-Seizure Medications
5.1.6 Stimulants
5.1.7 Cognitive Disorders And Dementia
5.1.8 Sleep Disorder Treatments
5.1.9 Substance Abuse Treatments
5.1.10 Hypnosis And Tranquilizers
5.1.11 Other
5.2 By Application - Global Drugs for Treating Mental Disorders Revenue & Forecasts
5.2.1 By Application - Global Drugs for Treating Mental Disorders Revenue, 2018-2023
5.2.2 By Application - Global Drugs for Treating Mental Disorders Revenue, 2024-2030
5.2.3 By Application - Global Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Drugs for Treating Mental Disorders Market Size, 2022 & 2030
6.2 By Region - Global Drugs for Treating Mental Disorders Revenue & Forecasts
6.2.1 By Region - Global Drugs for Treating Mental Disorders Revenue, 2018-2023
6.2.2 By Region - Global Drugs for Treating Mental Disorders Revenue, 2024-2030
6.2.3 By Region - Global Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Drugs for Treating Mental Disorders Revenue, 2018-2030
6.3.2 US Drugs for Treating Mental Disorders Market Size, 2018-2030
6.3.3 Canada Drugs for Treating Mental Disorders Market Size, 2018-2030
6.3.4 Mexico Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Drugs for Treating Mental Disorders Revenue, 2018-2030
6.4.2 Germany Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4.3 France Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4.4 U.K. Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4.5 Italy Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4.6 Russia Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4.7 Nordic Countries Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4.8 Benelux Drugs for Treating Mental Disorders Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Drugs for Treating Mental Disorders Revenue, 2018-2030
6.5.2 China Drugs for Treating Mental Disorders Market Size, 2018-2030
6.5.3 Japan Drugs for Treating Mental Disorders Market Size, 2018-2030
6.5.4 South Korea Drugs for Treating Mental Disorders Market Size, 2018-2030
6.5.5 Southeast Asia Drugs for Treating Mental Disorders Market Size, 2018-2030
6.5.6 India Drugs for Treating Mental Disorders Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Drugs for Treating Mental Disorders Revenue, 2018-2030
6.6.2 Brazil Drugs for Treating Mental Disorders Market Size, 2018-2030
6.6.3 Argentina Drugs for Treating Mental Disorders Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Treating Mental Disorders Revenue, 2018-2030
6.7.2 Turkey Drugs for Treating Mental Disorders Market Size, 2018-2030
6.7.3 Israel Drugs for Treating Mental Disorders Market Size, 2018-2030
6.7.4 Saudi Arabia Drugs for Treating Mental Disorders Market Size, 2018-2030
6.7.5 UAE Drugs for Treating Mental Disorders Market Size, 2018-2030
7 Drugs for Treating Mental Disorders Companies Profiles
7.1 Johnson and Johnson
7.1.1 Johnson and Johnson Company Summary
7.1.2 Johnson and Johnson Business Overview
7.1.3 Johnson and Johnson Drugs for Treating Mental Disorders Major Product Offerings
7.1.4 Johnson and Johnson Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.1.5 Johnson and Johnson Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Drugs for Treating Mental Disorders Major Product Offerings
7.2.4 Pfizer Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Drugs for Treating Mental Disorders Major Product Offerings
7.3.4 Eli Lilly Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Drugs for Treating Mental Disorders Major Product Offerings
7.4.4 GlaxoSmithKline Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Drugs for Treating Mental Disorders Major Product Offerings
7.5.4 AstraZeneca Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Drugs for Treating Mental Disorders Major Product Offerings
7.6.4 Bristol-Myers Squibb Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Teva Pharmaceutical
7.7.1 Teva Pharmaceutical Company Summary
7.7.2 Teva Pharmaceutical Business Overview
7.7.3 Teva Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
7.7.4 Teva Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.7.5 Teva Pharmaceutical Key News & Latest Developments
7.8 Dr. Reddy's Laboratories
7.8.1 Dr. Reddy's Laboratories Company Summary
7.8.2 Dr. Reddy's Laboratories Business Overview
7.8.3 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Major Product Offerings
7.8.4 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.8.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.9 Apotex Inc.
7.9.1 Apotex Inc. Company Summary
7.9.2 Apotex Inc. Business Overview
7.9.3 Apotex Inc. Drugs for Treating Mental Disorders Major Product Offerings
7.9.4 Apotex Inc. Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.9.5 Apotex Inc. Key News & Latest Developments
7.10 Mylan Pharmaceuticals
7.10.1 Mylan Pharmaceuticals Company Summary
7.10.2 Mylan Pharmaceuticals Business Overview
7.10.3 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.10.4 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.10.5 Mylan Pharmaceuticals Key News & Latest Developments
7.11 Par Pharmaceutical
7.11.1 Par Pharmaceutical Company Summary
7.11.2 Par Pharmaceutical Business Overview
7.11.3 Par Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
7.11.4 Par Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.11.5 Par Pharmaceutical Key News & Latest Developments
7.12 Aurobindo Pharma
7.12.1 Aurobindo Pharma Company Summary
7.12.2 Aurobindo Pharma Business Overview
7.12.3 Aurobindo Pharma Drugs for Treating Mental Disorders Major Product Offerings
7.12.4 Aurobindo Pharma Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.12.5 Aurobindo Pharma Key News & Latest Developments
7.13 Torrent Pharmaceuticals
7.13.1 Torrent Pharmaceuticals Company Summary
7.13.2 Torrent Pharmaceuticals Business Overview
7.13.3 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.13.4 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.13.5 Torrent Pharmaceuticals Key News & Latest Developments
7.14 Jubilant Lifesciences
7.14.1 Jubilant Lifesciences Company Summary
7.14.2 Jubilant Lifesciences Business Overview
7.14.3 Jubilant Lifesciences Drugs for Treating Mental Disorders Major Product Offerings
7.14.4 Jubilant Lifesciences Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.14.5 Jubilant Lifesciences Key News & Latest Developments
7.15 Sun Pharmaceutical
7.15.1 Sun Pharmaceutical Company Summary
7.15.2 Sun Pharmaceutical Business Overview
7.15.3 Sun Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
7.15.4 Sun Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.15.5 Sun Pharmaceutical Key News & Latest Developments
7.16 Sandoz (Novartis)
7.16.1 Sandoz (Novartis) Company Summary
7.16.2 Sandoz (Novartis) Business Overview
7.16.3 Sandoz (Novartis) Drugs for Treating Mental Disorders Major Product Offerings
7.16.4 Sandoz (Novartis) Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.16.5 Sandoz (Novartis) Key News & Latest Developments
7.17 Hansoh Pharmaceutical
7.17.1 Hansoh Pharmaceutical Company Summary
7.17.2 Hansoh Pharmaceutical Business Overview
7.17.3 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
7.17.4 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.17.5 Hansoh Pharmaceutical Key News & Latest Developments
7.18 WATSON Pharmaceuticals
7.18.1 WATSON Pharmaceuticals Company Summary
7.18.2 WATSON Pharmaceuticals Business Overview
7.18.3 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.18.4 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.18.5 WATSON Pharmaceuticals Key News & Latest Developments
7.19 Zhejiang Langhua Pharmaceuticals
7.19.1 Zhejiang Langhua Pharmaceuticals Company Summary
7.19.2 Zhejiang Langhua Pharmaceuticals Business Overview
7.19.3 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.19.4 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.19.5 Zhejiang Langhua Pharmaceuticals Key News & Latest Developments
7.20 Forest Laboratories
7.20.1 Forest Laboratories Company Summary
7.20.2 Forest Laboratories Business Overview
7.20.3 Forest Laboratories Drugs for Treating Mental Disorders Major Product Offerings
7.20.4 Forest Laboratories Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.20.5 Forest Laboratories Key News & Latest Developments
7.21 H.Lundbeck A/S
7.21.1 H.Lundbeck A/S Company Summary
7.21.2 H.Lundbeck A/S Business Overview
7.21.3 H.Lundbeck A/S Drugs for Treating Mental Disorders Major Product Offerings
7.21.4 H.Lundbeck A/S Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.21.5 H.Lundbeck A/S Key News & Latest Developments
7.22 Amneal Pharmaceuticals
7.22.1 Amneal Pharmaceuticals Company Summary
7.22.2 Amneal Pharmaceuticals Business Overview
7.22.3 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.22.4 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.22.5 Amneal Pharmaceuticals Key News & Latest Developments
7.23 Hetero Drugs
7.23.1 Hetero Drugs Company Summary
7.23.2 Hetero Drugs Business Overview
7.23.3 Hetero Drugs Drugs for Treating Mental Disorders Major Product Offerings
7.23.4 Hetero Drugs Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.23.5 Hetero Drugs Key News & Latest Developments
7.24 Macleods Pharmaceuticals
7.24.1 Macleods Pharmaceuticals Company Summary
7.24.2 Macleods Pharmaceuticals Business Overview
7.24.3 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.24.4 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.24.5 Macleods Pharmaceuticals Key News & Latest Developments
7.25 Silarx Pharmacueticals
7.25.1 Silarx Pharmacueticals Company Summary
7.25.2 Silarx Pharmacueticals Business Overview
7.25.3 Silarx Pharmacueticals Drugs for Treating Mental Disorders Major Product Offerings
7.25.4 Silarx Pharmacueticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.25.5 Silarx Pharmacueticals Key News & Latest Developments
7.26 Hikma Pharmaceuticals
7.26.1 Hikma Pharmaceuticals Company Summary
7.26.2 Hikma Pharmaceuticals Business Overview
7.26.3 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.26.4 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.26.5 Hikma Pharmaceuticals Key News & Latest Developments
7.27 Lupin Limited
7.27.1 Lupin Limited Company Summary
7.27.2 Lupin Limited Business Overview
7.27.3 Lupin Limited Drugs for Treating Mental Disorders Major Product Offerings
7.27.4 Lupin Limited Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.27.5 Lupin Limited Key News & Latest Developments
7.28 Prinston Pharmaceutical
7.28.1 Prinston Pharmaceutical Company Summary
7.28.2 Prinston Pharmaceutical Business Overview
7.28.3 Prinston Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
7.28.4 Prinston Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.28.5 Prinston Pharmaceutical Key News & Latest Developments
7.29 STI Pharma
7.29.1 STI Pharma Company Summary
7.29.2 STI Pharma Business Overview
7.29.3 STI Pharma Drugs for Treating Mental Disorders Major Product Offerings
7.29.4 STI Pharma Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.29.5 STI Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
